Diopsys introduced its first visual evoked potential (VEP) device at the American Academy of Pediatrics meeting in 2004, and has been leading the visual electrophysiology space ever since. Our Research and Development program is very important to the success of our vision testing devices, and our customers have benefited from our continuous product expansions. In addition to all of the clinical research done in the last 16 years, we currently have 15 studies running at several prestigious institutions, such as:
- Wills Eye Hospital
- Doheny Eye Institute
- New York Eye and Ear Infirmary
- University of Pittsburgh Medical Center (UPMC)
- UCSF Medical Center
Take a look at our brief history below to see where we came from, and where we're headed.
Diopsys is committed to visual electrophysiology. Our history and future are rooted in providing doctors with objective, functional information to aid in the early detection of vision disorders and enhance patient management through ERG and VEP vision testing.
Are you interesting in learning more about Diopsys, and our visual electrophysiology suite of tests?